Acurx Pharmaceuticals, Inc. (ACXP) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 9.54M | 7.69M | 6.11M | 6.16M | 4.81M | 3.86M | 5.98M | 6.58M | 9.11M | 7.71M | 7.16M | 9.24M | 7.39M | 9.38M | 10.95M | 9.21M | 11.32M | 13.25M | 14.99M | 17.44M |
| Cash & Short-Term Investments | 9.25M | 7.56B | 5.91M | 6.06M | 4.64M | 3.71M | 5.76M | 6.36M | 8.92M | 7.47M | 7.05M | 9.15M | 7.18M | 9.11M | 10.61M | 9.09M | 11.08M | 12.96M | 14.46M | 17.1M |
| Cash Only | 9.25M | 7.56B | 5.91M | 6.06M | 4.64M | 3.71M | 5.76M | 6.36M | 8.92M | 7.47M | 7.05M | 9.15M | 7.18M | 9.11M | 10.61M | 9.09M | 11.08M | 12.96M | 14.46M | 17.1M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 56.31K | 48.42K | 40.21K | 40.21K | 0 | 51.13K | 97.37K | 51.13K | 0 | 129.16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | -7.55B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.25K | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.25K | 0 | 0 | 0 | 0 |
| Total Assets | 9.54M | 7.69M | 6.11M | 6.16M | 4.81M | 3.86M | 5.98M | 6.58M | 9.11M | 7.71M | 7.16M | 9.24M | 7.39M | 9.38M | 10.95M | 9.26M | 11.32M | 13.25M | 14.99M | 17.44M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 98.52% | 99.32% | 2.05% | -6.42% | -47.24% | -49.96% | -16.42% | -28.75% | 23.34% | -17.78% | -34.6% | -0.25% | -34.77% | -29.25% | -26.98% | -46.91% | 279.71% | 311.11% | - | - |
| Total Current Liabilities | 2.53M | 2.42M | 2.47M | 2.59M | 2.49M | 3.24M | 3.32M | 3.15M | 3.11M | 3.04M | 3.22M | 3.02M | 2.07M | 2.06M | 1.18M | 473.88K | 633.03K | 843.91K | 712.44K | 1.92M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.5M | 2.41M | 52.71K | 42.98K | 21K | 537.63K | 247.21K | 42.31K | 21.42K | 716.31K | 206.81K | 35.89K | 20.39K | 542.89K | 296.65K | 26.09K | 15.63K | 508.34K | 252.12K | 20.24K |
| Current Ratio | 3.78x | 3.18x | 2.47x | 2.38x | 1.93x | 1.19x | 1.80x | 2.09x | 2.93x | 2.53x | 2.22x | 3.06x | 3.56x | 4.55x | 9.26x | 19.43x | 17.89x | 15.71x | 21.04x | 9.09x |
| Quick Ratio | 3.78x | 3.18x | 2.47x | 2.38x | 1.93x | 1.19x | 1.80x | 2.09x | 2.93x | 2.53x | 2.22x | 3.06x | 3.56x | 4.55x | 9.26x | 19.43x | 17.89x | 15.71x | 21.04x | 9.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.53M | 2.42M | 2.47M | 2.59M | 2.49M | 3.24M | 3.32M | 3.15M | 3.11M | 3.04M | 3.22M | 3.02M | 2.07M | 2.06M | 1.18M | 473.88K | 633.03K | 843.91K | 712.44K | 1.92M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -9.25M | -7.56B | -5.91M | -6.06M | -4.64M | -3.71M | -5.76M | -6.36M | -8.92M | -7.47M | -7.05M | -9.15M | -7.18M | -9.11M | -10.61M | -9.09M | -11.08M | -12.96M | -14.46M | -17.1M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 7.01M | 5.27M | 3.64M | 3.57M | 2.31M | 615.12K | 2.66M | 3.43M | 6M | 4.67M | 3.93M | 6.22M | 5.31M | 7.32M | 9.76M | 8.79M | 10.69M | 12.41M | 14.28M | 15.52M |
| Equity Growth % | 203.42% | 756.51% | 36.53% | 4.05% | -61.47% | -86.82% | -32.29% | -44.86% | 12.94% | -36.2% | -59.7% | -29.24% | -50.31% | -41.06% | -31.62% | -43.4% | 332.56% | 359.37% | - | - |
| Book Value per Share | 4.68 | 3.51 | 2.24 | 3.00 | 2.31 | 0.72 | 3.26 | 4.33 | 7.75 | 6.93 | 6.05 | 10.20 | 9.13 | 12.61 | 17.52 | 17.12 | 20.89 | 24.28 | 28.23 | 44.55 |
| Total Shareholders' Equity | 7.01M | 5.27M | 3.64M | 3.57M | 2.31M | 615.12K | 2.66M | 3.43M | 6M | 4.67M | 3.93M | 6.22M | 5.31M | 7.32M | 9.76M | 8.79M | 10.69M | 12.41M | 14.28M | 15.52M |
| Common Stock | 3.39K | 2.35K | 1.8K | 1.47K | 22.4K | 17.03K | 16.77K | 16K | 15.76K | 14.47K | 13.01K | 13.01K | 11.67K | 11.63K | 11.59K | 10.26K | 10.26K | 10.22K | 10.13K | 9.92K |
| Retained Earnings | -76.97M | -75.29M | -73.71M | -71.72M | -69.47M | -67.32M | -64.54M | -61.72M | -57.6M | -53.22M | -48.1M | -44.99M | -41.54M | -38.64M | -35.38M | -31.84M | -29.22M | -26.55M | -23.92M | -19.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.64M | -35.38M | -31.84M | -29.22M | -26.55M | -23.92M | -19.28M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |